✦ LIBER ✦

Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine?

✍ Scribed by Emmanuel Lorne; Hervé Dupont; Edward Abraham

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The antimicrobial peptide HBD-2 and the

✍ D. Varoga; E. Klostermeier; F. Paulsen; C. Wruck; S. Lippross; L. O. Brandenburg 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 399 KB

Amyloid beta peptide 1–40 enhances the a

✍ Miriam Lotz; Sandra Ebert; Hermann Esselmann; Asparouh I. Iliev; Marco Prinz; N 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

Effects of Toll-like receptor 2 agonist

✍ Johann Sellner; Denis Grandgirard; Christian Gianinazzi; Regine M. Landmann; Ste 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 437 KB

O7.2 Detection of Escherichia coli in me

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 303 KB

Polymorphisms of the toll-like receptor

✍ Nachtigall, I.; Tamarkin, A.; Tafelski, S.; Weimann, A.; Rothbart, A.; Heim, S.; 📂 Article 📅 2013 🏛 SAGE Publications 🌐 English ⚖ 374 KB

76. The NOD2 Agonist Muramyl-Di-Peptide

✍ W.M. Richardson; S.C. Gribar; M.F. Branca; S. Dai; A. Afrazi; J. Li; T. Prindle; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 213 KB